Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital factor XII deficiency is an autosomal recessive systemic dysfunction of the hemostatic pathway, that is due to a defect in the coagulation factor XII (FXII or Hageman factor), and is either asymptomatic or characterized by a prolonged activated partial thromboplastin time and an increased risk for thromboembolism. FXII deficiency is strongly associated with primary recurrent abortions.
Features include very common findings: Reduced factor XII activity and Prolonged partial thromboplastin time; and sometimes findings: Thromboembolism, Abnormal thrombosis, Retinal arteriolar occlusion, and Retinal vein occlusion. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Retinal arteriolar occlusion, Retinal vein occlusion |
F12 encodes coagulation factor XII (615 aa). Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Highest expression in Liver (376.0 TPM) and Esophagus Mucosa (10.0 TPM).
Congenital factor XII deficiency is caused by mutations in the F12 gene on chromosome 5.
The F12 protein participates in F12 T328R(20-328), F12 T328K(20-328), and F12 T328K (329-615) pathways.
F12 is classified as a druggable target (Druggable Genome, Enzyme, and Protease categories) with score 8.7.
Genetic testing for F12 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital factor XII deficiency has been reported in the published literature.
Phenotype severity distribution: 2 very common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for congenital factor XII deficiency.
34 publications have been identified in PubMed for congenital factor XII deficiency. Research spans Case Report / Case Series (56%), Review / Meta-Analysis (15%), and Basic Science / Preclinical (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 56% |
Data assembled from 7 of 12 sources · Last updated Oct 4, 2026, 3:02 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Arms and legs |
1 |
Penetrating foot ulcers |
Blood and immune system | 1 | Abnormal bleeding tendency (abnormal bleeding) |
Research summaries
5 |
15% |
Laboratory research | 3 | 9% |
Disease patterns and progression | 3 | 9% |
Other research | 2 | 6% |
Testing and diagnosis research | 1 | 3% |
Clinical study results | 1 | 3% |
Park KS (2026). [PMID: 42072805](https://pubmed.ncbi.nlm.nih.gov/42072805/). *Diagnostics (Basel)*. [Case Report / Case Series]
Demidova E (2026). [PMID: 41240290](https://pubmed.ncbi.nlm.nih.gov/41240290/). *Int J Hematol*. [Other]
Sugita Y (2026). [PMID: 41856860](https://pubmed.ncbi.nlm.nih.gov/41856860/). *J Cardiothorac Vasc Anesth*. [Case Report / Case Series]
Stępnicki J (2026). [PMID: 41977511](https://pubmed.ncbi.nlm.nih.gov/41977511/). *Int J Mol Sci*. [Review / Meta-Analysis]
Al Aamri I (2026). [PMID: 41087255](https://pubmed.ncbi.nlm.nih.gov/41087255/). *J Cardiothorac Vasc Anesth*. [Other]
Yang A (2026). [PMID: 41197808](https://pubmed.ncbi.nlm.nih.gov/41197808/). *J Thromb Haemost*. [Basic Science / Preclinical]
Li X (2026). [PMID: 41543089](https://pubmed.ncbi.nlm.nih.gov/41543089/). *Clin Lab*. [Case Report / Case Series]
Su Y (2026). [PMID: 41429486](https://pubmed.ncbi.nlm.nih.gov/41429486/). *J Matern Fetal Neonatal Med*. [Review / Meta-Analysis]
Kalinin DV (2026). [PMID: 41640375](https://pubmed.ncbi.nlm.nih.gov/41640375/). *Expert Opin Ther Pat*. [Review / Meta-Analysis]
Zormpa A (2026). [PMID: 41977339](https://pubmed.ncbi.nlm.nih.gov/41977339/). *Int J Mol Sci*. [Case Report / Case Series]
AI-curated news mentioning congenital factor XII deficiency
Updated Feb 11, 2026
A case report highlights acquired coagulation factor XIII deficiency leading to spontaneous splenic rupture. This rare condition underscores the need for awareness and further research into its implications.